Q4 2025 Alembic Pharmaceuticals Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to the Q4 FY25 earnings conference call of Alembic Pharmaceuticals Limited. We have with us today Mr. Pranav Amin, the Managing Director; Mr. Shaunak Amin, the Managing Director; Mr. RK Baheti, the Director of Finance and CFO; Mr. Ajay Kumar Desai, the Senior Vice President of Finance; Mr. Nilesh Wadhwa, the Head of International Business and Security.
(Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. RK Baheti. Thank you and over to you, sir.
Thank you. Good evening, everyone. Thank you all for joining the fourth-quarter (technical difficulty) annual results call for March 2025. I'm sure you have got all the financials, but let me briefly take you through the numbers.
During the quarter, very pleased to inform you that this quarter, our revenue grew 17% to touch INR1,770 crore. EBITDA is INR286 crore, which is 16% of sales,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
